GREY:CBICF - Post Discussion
Post by
bogdansz on Oct 22, 2018 9:53am
Financials and Earnings of MPX Bioceuticals
Financials
| Date | Cost Of Revenue | Operating Expenses | Total Revenue | Net Income | Gross Profit |
| 2018-06-30 | $67,534,000 | $8,321,000 | $87,006,000 | $8,990,000 | $19,472,000 |
| 2018-03-31 | $59,885,000 | $8,618,000 | $77,536,000 | $7,609,000 | $17,651,000 |
| 2017-12-31 | $51,225,000 | $6,896,000 | $65,591,000 | $3,356,000 | $14,366,000 |
| 2017-09-30 | $45,740,000 | $6,792,000 | $59,201,000 | $4,564,000 | $13,461,000 |
Earnings
| Date | Actual EPS | Estimated EPS | Consensus EPS | Fiscal Period | % Change |
| 2018-07-25 | $0.26 | $0.21 | $0.21 | Q2 2018 | 0.44% |
| 2018-04-25 | $0.22 | $0.17 | $0.17 | Q1 2018 | 0.47% |
| 2018-01-24 | $0.15 | $0.12 | $0.12 | Q4 2017 | 0.50% |
| 2017-10-25 | $0.13 | $0.15 | $0.15 | Q3 2017 | 0.18% |
Be the first to comment on this post